Related Experiment Video
Updated: Feb 17, 2026

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
Published on: November 20, 2017
Stellate ganglion block ameliorates vascular calcification by inhibiting endoplasmic reticulum stress
Wei Hao1, Rui Yang2, Yang Yang3
1Department of Anesthesiology, Hebei Provincial Hospital of traditional Chinese Medicine, Shijiazhuang 050011, China.
Insights
Stellate ganglion block (SGB) may treat vascular calcification (VC) by inhibiting sympathetic nervous activity and endoplasmic reticulum stress. This study shows SGB ameliorates VC in rats, offering a potential new therapeutic strategy.
Area of Science:
- Cardiovascular Research
- Nephrology
- Vascular Biology
Background:
- Vascular calcification (VC) significantly contributes to cardiovascular morbidity and mortality, with limited therapeutic options.
- Stellate ganglion block (SGB) is a sympathetic blockade procedure known to influence vascular tone.
- The potential impact of SGB on VC has not been previously investigated.
Purpose of the Study:
- To investigate the ameliorative effect of SGB on vascular calcification.
- To explore the underlying mechanisms, including sympathetic activity and endoplasmic reticulum stress (ERS).
Main Methods:
- Vascular calcification was induced in rats using vitamin D3 plus nicotine (VDN) and in rat aortic vascular smooth muscle cells (VSMC) in vitro.
- SGB was administered to VDN-induced calcified rats.
- Alkaline phosphatase (ALP) activity, calcium content, VSMC phenotype transformation, ERS markers, and plasma norepinephrine levels were assessed.
Main Results:
- SGB treatment ameliorated VDN-induced increases in ALP activity, calcium content, and VSMC osteoblastic transformation in rats.
- SGB attenuated endoplasmic reticulum stress (ERS) in calcified aortas; ERS inducers blocked SGB's benefits, while ERS inhibitors mimicked them.
- SGB reduced elevated plasma norepinephrine levels in VDN rats, and in vitro, norepinephrine exacerbated VSMC calcification and ERS.
Conclusions:
- SGB inhibits sympathetic nervous activity, subsequently preventing ERS activation and ameliorating VC.
- Sympathetic over-activation plays a critical role in VC pathogenesis.
- SGB presents a novel therapeutic strategy and target for the prevention and treatment of VC.
Aims:
Vascular calcification (VC) underlies substantial cardiovascular morbidity and mortality. No clinically therapies have emerged presently. Stellate ganglion block (SGB) is one of the most often used sympathetic blockade procedure, and regulates vascular dilation. However, the effect of SGB on VC is still unknown. Therefore, we aimed to identify the ameliorative effect of SGB on VC.
Key Finding:
In vivo VC was induced in rats by administering vitamin D3 plus nicotine (VDN), and in vitro calcification of rat aortic vascular smooth muscle cells (VSMC) was induced by β-glycerophosphate. In VDN rats, alkaline phosphatase (ALP) activity and Calcium contents were higher than that in control rats. The transformation of VSMC from contractile to osteoblast-like phenotype was observed in calcified aorta. SGB ameliorated the increase of ALP activity and Calcium content, and the transformation of VSMC in calcified aorta. The stimulation of endoplasmic reticulum stress (ERS) in calcified aorta was also attenuated by SGB treatment. The inducer of ERS, tunicamycin could block the beneficial effect of SGB on VC, and the ERS inhibitor, 4-PBA could mimic the amelioration of SGB. Furthermore, SGB attenuated the increased plasma levels of norepinephrine in VDN rats. In vitro experiments, norepinephrine exaggerated VSMC calcification, phenotype transformation and ERS.
Significance:
These results demonstrate that SGB could inhibit sympathetic nervous activity, and then prevent the activation of ERS followed by ameliorating VC. Sympathetic over-activation might play critical role in the pathogenesis of VC, which provides new strategy and target for therapy and prevention of VC.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers

